Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FLUCLORIC: Randomized Multicentric Phase III Study Comparing the Efficacy of 2 Reduced Intensity Conditioning Regimens (Clofarabine/Busulfan vs Fludarabine/Busulfan) in Adults With AML and Eligible to Allogeneic Stem Cell Transplantation

NCT05917405 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT05917405
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05917405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FLUCLORIC: Randomized Multicentric Phase III Study Comparing the Efficacy of 2 Reduced Intensity Conditioning Regimens (Clofarabine/Busulfan vs Fludarabine/Busulfan) in Adults With AML and Eligible to Allogeneic Stem Cell Transplantation
Lead sponsor
Nantes University Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
September 14, 2023
Completion date
September 14, 2028
Enrollment
302 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia in remission